Innate memory phenotype CD4 + T cells play a role in early protection against infection by Listeria monocytogenes in a CD30L-dependent manner

Microbiology and Immunology

Volumn 55, Issue 9, 2011, Pages 645-656

  Umeda, Kenji ^a   Sun, Xun ^a,b   Guo, Ying ^a   Yamada, Hisakata ^a   Shibata, Kensuke ^a   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD30L; Innate T cells; Listeria moncytogenes

Indexed keywords

CD30 LIGAND; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; INTERFERON PRODUCTION; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; SPLEEN;

ANIMALS; ANTIGENS, CD44; BACTERIAL LOAD; CD30 LIGAND; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; IMMUNOLOGIC MEMORY; INTERLEUKIN-12; INTERLEUKIN-15; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PERITONEAL CAVITY; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS;

LISTERIA; LISTERIA MONOCYTOGENES; MUS;

EID: 80052709287     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00362.x     Document Type: Article

References (49)

1. Mackaness G. B. (1962) Cellular resistance to infection. J. Exp. Med. 116: 381-406.
2. North R. J. (1970) The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J. Exp. Med. 132: 521-34.
3. Kaufmann S. H. E. (1993) Immunity to intracellular bacteria. Annu. Rev. Immunol. 11: 129-63.
4. Harty J. T., Lenz L. L., Bevan M. J. (1996) Primary and secondary immune response to Listeria monocytogenes. Curr. Opin. Immunol. 8: 526-30.
5. Unanue E. R. (1997) Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158: 11-25.
6. Pamer E. G. (2004) Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-23.
7. Unanue E. R. (1997) Interrelationship among macrophages, natural killer cells and neutrophils in early stage of Listeria resistance. Curr. Opin. Immunol. 9: 35-43.
8. Prince A. L., Yin C. C., Enos M. E., Felices M., Berg L. J. (2009) The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development. Immunol. Rev. 228: 115-31.
9. Hiromatsu K., Yoshikai Y., Matsuzaki G., Ohga S., Muramori K., Matsumoto K., Bluestone J. A., Nomoto K. (1992) A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175: 49-56.
10. + TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur. J. Immunol. 25: 3321-5.
11. Kerksiek K. M., Busch D. H., Pilip I. M., Allen S. E., Pamer E. G. (1999) H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J. Exp. Med. 190: 195-204.
12. + T cells have different requirements for active Itk for their development. J. Immunol. 180: 6544-52.
13. Croft M. (2003) Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-20.
14. Watts T. H. (2005) TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
15. Sabbagh L., Snell L. M., Watts T. H. (2007) TNF family ligands define niches for T cell memory. Trends. Immunol. 28: 333-9.
16. Clement M. V., Stamenkovic I. (1994) Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180: 557-67.
17. Tartaglia L. A., Ayres T. M., Wong G. H., Goeddel D. V. (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74: 845-53.
18. Yang Y., Wilson J. M. (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science. 273: 1862-4.
19. Hintzen, R. Q., Lens, S. M., Lammers, K., Kuiper, H., Beckmann, M. P., Van Lier, R. A. (1995) Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154: 2612-23.
20. Smith C. A., Gruss H. J., Davis T., Anderson D., Farrah T., Baker E., Sutherland G. R., Brannan C. I., Copeland N. G., Jenkins N. A., Grabstein K. H., Gliniak B., McAlister I. B., Fanslow W., Alderson M., Falk B., Gimpel S., Gills S., Din W. S., Goodwin R. G., Armitage R. J. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokine with homology to TNF. Cell. 73: 1349-60.
21. Shimozato O., Taked K., Ygita H., Okumura K. (1999) Expression of CD30 ligand (CD153) on murine activated T cells. Biochem. Biophys. Res. Commun. 256: 519-26.
22. Kennedy M. K., Willis C. R., Armitage R. J. (2006) Deciphering CD30 ligand biology and its role in humoral immunity. Immunology. 118: 143-52.
23. Lane P. J., Gaspal F. M., Kim M. Y. (2005) Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization. Nat. Rev. Immunol. 5: 655-60.
24. Dürkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. (1992) Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 68: 421-7.
25. Ellis T. M., Simms P. E., Slivnick D. J., Jack H. M., Fisher R. I. (1993) CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO +T cells. J. Immunol. 151: 2380-9.
26. Bowen M. A., Lee R. K., Miragliotta G., Nam S. Y., Podack E. R. (1996) Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156: 442-9.
27. Tarkowski M. (2003) Expression and a role of CD30 in regulation of T-cell activity. Curr. Opin. Hematol. 10: 267-71.
28. Romagnani S., Del Prete G., Maggi E., Chilosi M., Caligaris-Cappio F., Pizzolo G. (1995) CD30 and type 2 T helper (Th2) responses. J. Leukoc. Biol. 57: 726-30.
29. Bengtsson A. (2001) The role of CD30 in atopic disease. Allergy. 56: 593-603.
30. Polte T., Behrendt A. K., Hansen G. (2006) Direct evidence for a critical role of CD30 in the development of allergic asthma. J. Allergy Clin. Immunol. 118: 942-8.
31. Munk M. E., Kern P., Kaufmann S. H. (1997) Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int. Immunol. 9: 713-20.
32. Flórido M., Borges M., Yagita H., Appelberg R. (2004) Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol. 76: 1039-346.
33. + T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends. Immunol. 22: 72-7.
34. Saraiva M., Smith P., Fallon P. G., Alcami A. (2002) Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J. Exp. Med. 196: 829-39.
35. Zhang Z. X., Yang L., Young K. J., DuTemple B., Zhang L. (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6: 782-9.
36. + T cells via a CD30-dependent mechanism. J. Clin.Invest.113: 310-7.
37. + T cell-mediated graft-versus-host disease. J. Immunol. 173: 2933-41.
38. Dunn P. L., North R. J. (1991) Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59, 2892-900.
39. Sallusto F., Lanzavecchia A. (2009) Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-82.
40. Van Leeuwen E. M., Sprent J., Surh C. D. (2009) Generation and maintenance of memory CD4(+) T cells. Curr. Opin. Immunol. 21: 167-72.
41. Nishimura H., Hiromatsu K., Kobayashi N., Grabstein K. H., Paxton R., Sugamura K., Bluestone J. A., Yoshikai Y. (1996) IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection. J. Immunol. 156: 663-9.
42. Waldmann T. A. (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6: 595-601.
43. Ma A., Koka R., Burkett P. (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-79.
44. Purton J. F, Tan J. T, Rubinstein M. P, Kim D. M, Sprent J., Surh C. D. (2007) AntiviralCD4+ memory T cells are IL-15 dependent. J. Exp. Med. 204: 951-61.
45. Lee S. Y., Lee S. Y., Kandala G., Liou M. L., Liou H. C., Choi Y. (1996) CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc. Natl. Acad. Sci. USA. 93: 9699-03.
46. Duckett C. S., Gedrich R. W., Gilfillan M. C., Thompson C. B. (1997) Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17: 1535-42.
47. + T cells. J. Immunol. 175: 4627-34.
48. Tang C., Yamada H., Shibata K., Muta H., Wajjwalku W., Podack E. R., Yoshikai Y. (2008) A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. J. Immunol. 181: 6316-27.
49. Sun X., Somada S., Shibata K., Muta H., Yamada H., Yoshihara H., Honda K., Nakamura K., Takayanagi R., Tani K., Podack E. R., Yoshikai Y. (2008) A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Gastroenterology. 134: 447-58.